Health
Arthritis drug trialled as potential treatment for COVID-19 – Arab News
LONDON: The experimental arthritis drug, otilimab, is being trialled as a potential treatment for COVID-19. The first patient, administered with the drug, is currently being cared for at Manchester Royal Infirmary (MRI), part of Manchester University NHS Foun…
LONDON: The experimental arthritis drug, otilimab, is being trialled as a potential treatment for COVID-19.
The first patient, administered with the drug, is currently being cared for at Manchester Royal Infirmary (MRI), part of Manchester University NHS Foundation Trust (MFT).
The OSCAR study (Otilimab in Severe COVID-19 Related Disease) is sponsored and funded by the pharmaceutical company GlaxoSmithKline.
The study at the MRI is being led by Dr. Andy Martin, an Intensive Care and Anaest…
-
Noosa News22 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News23 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General23 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News22 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland